Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

IGILUC 2019 /
Role of interventional oncology for immunology treatment

18th - 19th Apr 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.05.19
Views: 552

Prof Thierry De Baere - Institut Gustave Roussy, Paris, France

Prof Thierry De Baere speaks to ecancer at the 2019 International Gastrointestinal, Liver and Uro-Oncology Conference (IGILUC) in Cairo about the role of interventional oncology for immunology treatment.

He discusses what is needed for better delivery of immuno-oncology treatment in cancer patients including applying a local treatment to the tumour and turning 'cold' tumours to 'hot' ones.

Prof De Baere explains that an option being studied is to inject directly inside the tumour which causes the body to make its own fabrication of a vaccine inside the tumour.

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation